|
Zenith Drugs Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
111.81 Cr.
|
P/BV
|
1.80
|
Book Value (Rs.)
|
36.28
|
|
52 Week High/Low (Rs.)
|
113/47
|
FV/ML
|
10/800
|
P/E(X)
|
15.62
|
|
Bookclosure
|
25/09/2024
|
EPS (Rs.)
|
4.18
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 62.21 | 69.41 |
| Total Income From Operations | 62.21 | 69.41 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 39.85 | 44.30 |
| Increase/Decrease in Stocks | -0.04 | 1.40 |
| Employees Cost | 2.66 | 3.43 |
| Depreciation | 0.68 | 0.63 |
| Other Expenses | 12.45 | 10.66 |
| Total Expenses | 55.59 | 60.42 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 6.62 | 8.99 |
| Other Income | 2.05 | 0.08 |
| P/L Before Interest, Excpt. Items & Tax | 8.67 | 9.07 |
| Interest | 1.54 | 1.46 |
| P/L Before Exceptional Items & Tax | 7.13 | 7.61 |
| Exceptional Items | -1.27 | -0.02 |
| P/L Before Tax | 5.85 | 7.59 |
| Tax | 1.60 | 2.20 |
| P/L After Tax from Ordinary Activities | 4.25 | 5.39 |
| Net Profit/Loss For the Period | 4.25 | 5.39 |
| Minority Interest | -0.05 | 0.00 |
| Share Of P/L Of Associates | -0.01 | 0.01 |
| Net P/L After Minority Interest & Share Of Associates | 9.59 | 5.41 |
| | | |
| Equity Share Capital | 17.15 | 12.00 |
| Reserves And Surplus | 45.12 | 0.00 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 2.48 | 4.49 |
| Diluted EPS (Rs.) | 2.48 | 4.49 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 2.48 | 4.49 |
| Diluted EPS (Rs.) | 5.59 | 4.49 |
| | | |
| PBITOE Margin (%) | 10.63 | 12.95 |
| PBTE Margin (%) | 11.45 | 10.96 |
| PBT Margin (%) | 9.40 | 10.93 |
| PAT Margin (%) | 6.83 | 7.77 |
| PAT After MI And SOA Margin (%) | 15.41 | 7.78 |
